Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
Dimopoulos, Meletios A, Prof, Moreau, Philippe, Prof, Palumbo, Antonio, Prof, Joshua, Douglas, Prof, Pour, Ludek, Prof, Hájek, Roman, Prof, Facon, Thierry, Prof, Ludwig, Heinz, Prof, Oriol, Albert, Prof, Goldschmidt, Hartmut, Prof, Rosiñol, Laura, Prof, Straub, Jan, Prof, Suvorov, Aleksandr, Prof, Araujo, Carla, Prof, Rimashevskaya, Elena, Prof, Pika, Tomas, Prof, Gaidano, Gianluca, Prof, Weisel, Katja, Prof, Goranova-Marinova, Vesselina, Prof, Schwarer, Anthony, Prof, Minuk, Leonard, Prof, Masszi, Tamás, Prof, Karamanesht, Ievgenii, Prof, Offidani, Massimo, Prof, Hungria, Vania, Prof, Spencer, Andrew, Prof, Orlowski, Robert Z, MD, Gillenwater, Heidi H, MD, Mohamed, Nehal, PhD, Feng, Shibao, PhD, Chng, Wee-Joo, Prof
Published in The lancet oncology (01.01.2016)
Published in The lancet oncology (01.01.2016)
Get full text
Journal Article
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar, S Vincent, Prof, Dimopoulos, Meletios A, Prof, Palumbo, Antonio, Prof, Blade, Joan, Md, Merlini, Giampaolo, Prof MD, Mateos, María-Victoria, MD, Kumar, Shaji, Prof, Hillengass, Jens, MD, Kastritis, Efstathios, MD, Richardson, Paul, Prof, Landgren, Ola, MD, Paiva, Bruno, MD, Dispenzieri, Angela, Prof, Weiss, Brendan, MD, LeLeu, Xavier, MD, Zweegman, Sonja, Prof, Lonial, Sagar, Prof, Rosinol, Laura, MD, Zamagni, Elena, MD, Jagannath, Sundar, Prof, Sezer, Orhan, Prof, Kristinsson, Sigurdur Y, MD, Caers, Jo, MD, Usmani, Saad Z, MD, Lahuerta, Juan José, MD, Johnsen, Hans Erik, Prof, Beksac, Meral, Prof, Cavo, Michele, Prof, Goldschmidt, Hartmut, Prof, Terpos, Evangelos, MD, Kyle, Robert A, Prof, Anderson, Kenneth C, Prof, Durie, Brian G M, Prof, Miguel, Jesus F San, Prof
Published in The lancet oncology (01.11.2014)
Published in The lancet oncology (01.11.2014)
Get full text
Journal Article
Web Resource
Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data
Palumbo, Antonio, Prof Dr, Bringhen, Sara, MD, Kumar, Shaji K, MD, Lupparelli, Giulia, BS, Usmani, Saad, MD, Waage, Anders, Prof, Larocca, Alessandra, MD, van der Holt, Bronno, PhD, Musto, Pellegrino, MD, Offidani, Massimo, MD, Petrucci, Maria T, MD, Evangelista, Andrea, MS, Zweegman, Sonja, MD, Nooka, Ajay K, MD, Spencer, Andrew, Prof, Dimopoulos, Meletios A, Prof, Hajek, Roman, MD, Cavo, Michele, Prof, Richardson, Paul, Prof, Lonial, Sagar, Prof, Ciccone, Giovannino, MD, Boccadoro, Mario, Prof, Anderson, Kenneth, MD, Barlogie, Bart, Prof, Sonneveld, Pieter, Prof, McCarthy, Philip L, Prof
Published in The lancet oncology (01.03.2014)
Published in The lancet oncology (01.03.2014)
Get full text
Journal Article
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
Delforge, Michel, Prof, Bladé, Joan, Prof, Dimopoulos, Meletios A, Prof, Facon, Thierry, Prof, Kropff, Martin, MD, Ludwig, Heinz, Prof, Palumbo, Antonio, Prof, Van Damme, Philip, MD, San-Miguel, Jesús F, Prof, Sonneveld, Pieter, Prof
Published in The lancet oncology (01.11.2010)
Published in The lancet oncology (01.11.2010)
Get full text
Journal Article
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial
San-Miguel, Jesús F, Hungria, Vania T M, Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A, Elghandour, Ashraf, Jedrzejczak, Wieslaw W, Günther, Andreas, Nakorn, Thanyaphong N, Siritanaratkul, Noppadol, Schlossman, Robert L, Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae H, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Binlich, Florence, Richardson, Paul G
Published in The Lancet. Haematology (01.11.2016)
Published in The Lancet. Haematology (01.11.2016)
Get more information
Journal Article
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Dimopoulos, Meletios A, Dr Prof, Trotman, Judith, Prof, Tedeschi, Alessandra, MD, Matous, Jeffrey V, Prof, Macdonald, David, MD, Tam, Constantine, MBBS, Tournilhac, Olivier, Prof, Ma, Shuo, MD, Oriol, Albert, MD, Heffner, Leonard T, MD, Shustik, Chaim, Prof, García-Sanz, Ramón, Prof, Cornell, Robert F, MD, de Larrea, Carlos Fernández, MD, Castillo, Jorge J, MD, Granell, Miquel, MD, Kyrtsonis, Marie-Christine, MD, Leblond, Veronique, Prof, Symeonidis, Argiris, MD, Kastritis, Efstathios, MD, Singh, Priyanka, MS, Li, Jianling, MS, Graef, Thorsten, MD, Bilotti, Elizabeth, MSN, Treon, Steven, MD, Buske, Christian, Prof
Published in The lancet oncology (01.02.2017)
Published in The lancet oncology (01.02.2017)
Get full text
Journal Article